Literature DB >> 415630

Metabolic responses to enteral and parenteral nutrition.

H L Lickley, N S Track, M Vranic, K D Bury.   

Abstract

Seven pairs of rats were simultaneously infused with a chemically formulated nutritionally complete amino acid-glucose diet which was delivered, at the same rate, into a central vein or into a feeding gastrostomy. The intragastrically infused rats showed greater weight gain than did the intravenously infused rats. This could not be explained by fluid retention since intake and output were similar in the two groups of animals. There was a greater increase in serum immunoreactive insulin (IRI) at day 8 in the intragastrically infused animals, but a smaller increment in serum immunoreactive pancreatic glucagon (IRG) at that point. Levels of enteroglucagon or glucagon-like immunoreactivity (GLI) were maintained in the intragastrically infused rats but declined markedly in the intravenously infused rats. It is possible that the greater release of IRI seen with the intragastric amino acid-glucose feeding contributes to better disposal of nutrients and greater weight gain. The presence of nutrients in the intestinal lumen may have stimulated the release of GLI, which in turn is insulinotropic.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 415630     DOI: 10.1016/0002-9610(78)90092-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Mechanisms of release of gastro-entero-pancreatic endocrine cells.

Authors:  N S Track
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

2.  Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis.

Authors:  F A Moore; D V Feliciano; R J Andrassy; A H McArdle; F V Booth; T B Morgenstein-Wagner; J M Kellum; R E Welling; E E Moore
Journal:  Ann Surg       Date:  1992-08       Impact factor: 12.969

3.  The effect of parenteral and enteral nutrition on portal and systemic immunoreactivities of gastrin, glucagon and vasoactive intestinal polypeptide (VIP).

Authors:  Z Gimmon; R F Murphy; M H Chen; C A Nachbauer; J E Fischer; S N Joffe
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.